Loss of the endothelial glucocorticoid receptor prevents the therapeutic protection afforded by Dexamethasone after LPS

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Goodwin, Julie E ^a   Feng, Yan ^a   Velazquez, Heino ^b   Zhou, Han ^a   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME INHIBITION; ENZYME SYNTHESIS; MALE; MORBIDITY; MORNING DOSAGE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; UPREGULATION; ANIMAL; DRUG EFFECTS; ENDOTHELIUM; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; ENDOTHELIUM; GLUCOCORTICOIDS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; NF-KAPPA B; NITRIC OXIDE; RECEPTORS, GLUCOCORTICOID; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907720835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108126     Document Type: Article

References (30)

1. Stolte EH, van Kemenade BM, Savelkoul HF, Flik G (2006) Evolution of glucocorticoid receptors with different glucocorticoid sensitivity. J Endocrinol 190: 17-28.
2. Berry LJ, Smythe DS (1964) Effects of Bacterial Endotoxins on Metabolism. Vii. Enzyme Induction and Cortisone Protection. J Exp Med 120: 721-732.
3. Spink WW, Anderson D (1954) Experimental studies on the significance of endotoxin in the pathogenesis of brucellosis. J Clin Invest 33: 540-548.
4. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353: 1711-1723.
5. Saklatvala J (2002) Glucocorticoids: do we know how they work? Arthritis Res 4: 146-150.
6. Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, et al. (2014) Abandon the mouse research ship? Not just yet! Shock 41: 463-475.
7. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512.
8. Tronche F, Kellendonk C, Reichardt HM, Schutz G (1998) Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev 8: 532-538.
9. Goodwin JE, Zhang J, Gonzalez D, Albinsson S, Geller DS (2011) Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension. J Hypertens 29: 1347-1356.
10. Goodwin JE, Feng Y, Velazquez H, Sessa WC (2013) Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A 110: 306-311.
11. Langklotz S, Schakermann M, Narberhaus F (2011) Control of lipopolysaccharide biosynthesis by FtsH-mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria. J Bacteriol 193: 1090-1097.
12. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, et al. (2003) Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775.
13. Laubach VE, Foley PL, Shockey KS, Tribble CG, Kron IL (1998) Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice. Am J Physiol 275: H2211-2218.
14. Fernandez-Hernando C, Ackah E, Yu J, Suarez Y, Murata T, et al. (2007) Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab 6: 446-457.
15. Hinds TD Jr, Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, et al. (2010) Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol 24: 1715-1727.
16. Figlewicz DP, Filkins JP (1978) Dexamethasone antagonism of glucose dyshomeostasis in endotoxin shock. Circ Shock 5: 317-323.
17. Kaddoura S, Curzen NP, Evans TW, Firth JD, Poole-Wilson PA (1996) Tissue expression of endothelin-1 mRNA in endotoxaemia. Biochem Biophys Res Commun 218: 641-647.
18. Wang X, Nelin LD, Kuhlman JR, Meng X, Welty SE, et al. (2008) The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci 83: 671-680.
19. Lee JI, Burckart GJ (1998) Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38: 981-993.
20. Bonin CP, Baccarin RY, Nostell K, Nahum LA, Fossum C, et al. (2013) Lipopolysaccharide-induced inhibition of transcription of tlr4 in vitro is reversed by dexamethasone and correlates with presence of conserved NFkappaB binding sites. Biochem Biophys Res Commun 432: 256-261.
21. Guerrero J, Gatica HA, Rodriguez M, Estay R, Goecke IA (2013) Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay. Crit Care 17: R107.
22. Taniguchi Y, Iwasaki Y, Tsugita M, Nishiyama M, Taguchi T, et al. (2010) Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction. Endocrinology 151: 3204-3213.
23. Oakley RH, Sar M, Cidlowski JA (1996) The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 271: 9550-9559.
24. Webster JC, Oakley RH, Jewell CM, Cidlowski JA (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 98: 6865-6870.
25. Oakley RH, Webster JC, Sar M, Parker CR Jr, Cidlowski JA (1997) Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 138: 5028-5038.
26. Haim YO, Unger ND, Souroujon MC, Mittelman M, Neumann D (2014) Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone. Sci Rep 4: 4323.
27. Ling J, Kumar R (2012) Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy. Cancer Lett 322: 119-126.
28. Sorrells SF, Caso JR, Munhoz CD, Hu CK, Tran KV, et al. (2013) Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation. J Neurosci 33: 7877-7889.
29. Gupte R, Muse GW, Chinenov Y, Adelman K, Rogatsky I (2013) Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc Natl Acad Sci U S A 110: 14616-14621.
30. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA (2001) Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7: 1291-1297.